UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$191M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$157M |
| 3 |
Pfizer
PFE
|
+$139M |
| 4 |
3M
MMM
|
+$131M |
| 5 |
Meta Platforms (Facebook)
META
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altera Corp
ALTR
|
+$288M |
| 2 |
Intercontinental Exchange
ICE
|
+$247M |
| 3 |
RKT
ROCK-TENN COMPANY CL-A
RKT
|
+$142M |
| 4 |
Yelp
YELP
|
+$140M |
| 5 |
Salesforce
CRM
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.28% |
| 2 | Financials | 14.69% |
| 3 | Technology | 14.25% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACHN
976
DELISTED
Achillion Pharmaceuticals
ACHN
| $5.81M | 0.01% |
655,459
+17,000
| +3% | +$161K |
|
977
Ambev
ABEV
$47B
| $5.79M | 0.01% |
949,400
-61,000
| -6% | -$377K |
|
|
SGMO
978
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $5.76M | 0.01% |
519,096
-2,602
| -0.5% | -$33.5K |
|
979
Dr. Reddy's Laboratories
RDY
$10.1B
| $5.75M | 0.01% |
519,900
-656,050
| -56% | -$7.24M |
|
980
Compañía de Minas Buenaventura
BVN
$8.19B
| $5.75M | 0.01% |
553,752
+15,600
| +3% | +$171K |
|
|
PRXL
981
DELISTED
Parexel International Corp
PRXL
| $5.71M | 0.01% |
88,744
-54,103
| -38% | -$3.65M |
|
982
Gaming and Leisure Properties
GLPI
$12.6B
| $5.7M | 0.01% |
155,460
+102,679
| +195% | +$3.77M |
|
983
Valmont Industries
VMI
$9.72B
| $5.7M | 0.01% |
47,917
-147,617
| -75% | -$18.2M |
|
|
UFS
984
DELISTED
DOMTAR CORPORATION (New)
UFS
| $5.68M | 0.01% |
137,217
-22,233
| -14% | -$973K |
|
985
Cadence Design Systems
CDNS
$93.8B
| $5.59M | 0.01% |
284,275
+25,295
| +10% | +$490K |
|
|
PDM
986
Piedmont Realty Trust
PDM
$1.21B
| $5.58M | 0.01% |
317,313
+28,608
| +10% | +$509K |
|
987
Saia
SAIA
$9.99B
| $5.54M | 0.01% |
141,136
-162
| -0.1% | -$6.7K |
|
988
Main Street Capital
MAIN
$5.31B
| $5.52M | 0.01% |
172,897
-47,060
| -21% | -$1.47M |
|
|
SWI
989
DELISTED
SOLARWINDS INC COM STK (DE)
SWI
| $5.49M | 0.01% |
119,031
-37,091
| -24% | -$1.82M |
|
990
First Solar
FSLR
$26.2B
| $5.46M | 0.01% |
116,206
+3,565
| +3% | +$199K |
|
991
Healthcare Realty
HR
$7.02B
| $5.44M | 0.01% |
227,294
+25,930
| +13% | +$663K |
|
|
QTS
992
DELISTED
QTS REALTY TRUST, INC.
QTS
| $5.4M | 0.01% |
148,201
+141,801
| +2,216% | +$5.25M |
|
|
SGYP
993
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $5.3M | 0.01% |
638,700
+3,300
| +0.5% | +$16K |
|
994
Axalta
AXTA
$8.05B
| $5.29M | 0.01% |
+159,965
| New | +$5.28M |
|
995
American Eagle Outfitters
AEO
$3.03B
| $5.27M | 0.01% |
305,887
+183,893
| +151% | +$3.09M |
|
996
Factset
FDS
$9.76B
| $5.26M | 0.01% |
32,371
-92,962
| -74% | -$15.1M |
|
|
BRLI
997
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
| $5.24M | 0.01% |
126,973
-32,367
| -20% | -$1.16M |
|
998
Broadridge
BR
$19.5B
| $5.22M | 0.01% |
104,358
+11,000
| +12% | +$586K |
|
|
HCC
999
DELISTED
HCC INSURANCES HOLDINGS INC
HCC
| $5.21M | 0.01% |
67,803
+5,200
| +8% | +$324K |
|
1000
JetBlue
JBLU
$2.42B
| $5.16M | ﹤0.01% |
+248,647
| New | +$5.04M |
|
Similar funds
UBS AM's Q2 2015 Portfolio in Review
As of Q2 2015, UBS AM held 2,771 positions worth $104B, up 0.68% from $104B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2015 filing shows 148 new, 1,779 increased, 566 reduced and 77 closed positions. Its largest new stake was Viatris: 1,260,214 shares worth $85.5M. The largest sale was Altera Corp, an estimated $288M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Financials and Technology.
- UBS AM's largest Q2 2015 buy was Viatris: 1,260,214 shares worth $85.5M.
- UBS AM added most to Allergan plc in Q2 2015, an estimated $191M increase.
- UBS AM's biggest Q2 2015 reduction was Altera Corp, cutting an estimated $288M.
- UBS AM fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $78.3M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q2 2015.
- UBS AM opened 148 new positions and closed 77 in Q2 2015.
- UBS AM's portfolio value rose 0.68% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q2 2015, filed 12 Aug 2015.